Search research articles
Contact Us
Filters
Showing results (291-300 of 320) with videos related to
Page
of 32
Sort By:
Open Heart
|
September 4, 2023
Time to TAVI: streamlining the pathway to treatment
Lynsey Jane Hewitson, Suzane Cadiz, Sameeha Al-Sayed, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
August 22, 2013
Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA
Lawrence M Phillips, Rory Hachamovitch, Daniel S Berman, et al.
Circulation. Cardiovascular Quality and Outcomes
|
September 20, 2024
International Variation in Health Status Benefits in Patients Undergoing Initial Invasive Versus Conservative Management for Chronic Coronary Disease: Insights From the ISCHEMIA Trial
Nobuhiro Ikemura, John A Spertus, Dan Nguyen, et al.
European Journal of Heart Failure
|
February 23, 2021
Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trial
Ninian N Lang, Faheem A Ahmad, John G Cleland, et al.
Lancet (London, England)
|
August 23, 2011
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial
John G F Cleland, John R Teerlink, Roxy Senior, et al.
JAMA Cardiology
|
October 25, 2023
Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial
Divaka Perera, Matthew Ryan, Holly P Morgan, et al.
Circulation
|
June 1, 2021
Natural History of Patients With Ischemia and No Obstructive Coronary Artery Disease: The CIAO-ISCHEMIA Study
Harmony R Reynolds, Michael H Picard, John A Spertus, et al.
Circulation. Cardiovascular Interventions
|
April 12, 2022
Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial
Sripal Bangalore, John A Spertus, Susanna R Stevens, et al.
Echo Research and Practice
|
February 21, 2025
Multi-societal expert consensus statement on the safe administration of ultrasound contrast agents
Jordan B Strom, Andrew Appis, Richard G Barr, et al.
European Heart Journal
|
August 30, 2024
2024 ESC Guidelines for the management of chronic coronary syndromes
Christiaan Vrints, Felicita Andreotti, Konstantinos C Koskinas, et al.
Page
of 32
Search research articles
Search
Showing results (291-300 of 320) with videos related to
Sort By:
Page
of 32
Open Heart
|
September 4, 2023
Time to TAVI: streamlining the pathway to treatment
Lynsey Jane Hewitson, Suzane Cadiz, Sameeha Al-Sayed, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
August 22, 2013
Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA
Lawrence M Phillips, Rory Hachamovitch, Daniel S Berman, et al.
Circulation. Cardiovascular Quality and Outcomes
|
September 20, 2024
International Variation in Health Status Benefits in Patients Undergoing Initial Invasive Versus Conservative Management for Chronic Coronary Disease: Insights From the ISCHEMIA Trial
Nobuhiro Ikemura, John A Spertus, Dan Nguyen, et al.
European Journal of Heart Failure
|
February 23, 2021
Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trial
Ninian N Lang, Faheem A Ahmad, John G Cleland, et al.
Lancet (London, England)
|
August 23, 2011
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial
John G F Cleland, John R Teerlink, Roxy Senior, et al.
JAMA Cardiology
|
October 25, 2023
Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial
Divaka Perera, Matthew Ryan, Holly P Morgan, et al.
Circulation
|
June 1, 2021
Natural History of Patients With Ischemia and No Obstructive Coronary Artery Disease: The CIAO-ISCHEMIA Study
Harmony R Reynolds, Michael H Picard, John A Spertus, et al.
Circulation. Cardiovascular Interventions
|
April 12, 2022
Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial
Sripal Bangalore, John A Spertus, Susanna R Stevens, et al.
Echo Research and Practice
|
February 21, 2025
Multi-societal expert consensus statement on the safe administration of ultrasound contrast agents
Jordan B Strom, Andrew Appis, Richard G Barr, et al.
European Heart Journal
|
August 30, 2024
2024 ESC Guidelines for the management of chronic coronary syndromes
Christiaan Vrints, Felicita Andreotti, Konstantinos C Koskinas, et al.
Page
of 32